top of page

- Oct 31, 2021

Neurotech Pharmaceuticals Appoints Thomas Aaberg Jr., M.D. as Chief Medical Officer

View PDF Version

Press release - Tom Aaberg CMO

.pdf

Download PDF • 272KB

Recent Posts

Neurotech Pharmaceuticals, Inc. Expands Executive Team with the Appointment of Scott Hunter as Chief

Neurotech Pharmaceuticals Announces Positive Phase 3 Topline Results for NT-501 Implant in MacTel

Neurotech Chief Medical Officer authors article in The Ophthalmologist

bottom of page